{
  "id": 4858390,
  "title": "VivoSim Labs to Add Rat Liver Model to NAMkind Platform",
  "url": "https://urgent.news/2026/09/01/vivosim-labs-to-add-rat-liver-model-to-namkind-platform",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-01T12:18:42.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/vivosim-labs-to-add-rat-liver-model-to-namkind-platform"
  },
  "original_language": "en",
  "account": null,
  "summary": "New cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from risks that may translate to humans SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced plans to […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}